| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.3 |